NOD B Cells in Determinant Spreading of T Cell Immunity
NODB 细胞在 T 细胞免疫的决定性传播中
基本信息
- 批准号:6733555
- 负责人:
- 金额:$ 7.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-15 至 2006-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Our previous studies, as well as those of others, have found that NOD mice develop spontaneous splenic Th1 cell responses to GAD and its peptide determinants, which then spread intra-molecularly and inter-molecularly to other beta-cell autoantigens during the process of T1DM. Treatment of young NOD mice with single beta-cell antigen primes Th2 responses and the induced Th2 responses spread to other unrelated beta cell antigens, which is associated with the inhibition of disease progression. However, little is known about the role of antigen presenting cells (APC) in the determinant spreading of T cell autoimmunity in NOD mice. B cells are likely to be good candidates for mediating determinant spreading of T cell autoimmunity as B cells can concentrate antigen by capturing antigen via its antigen receptor, efficiently process and present antigen to T cells. Recent studies have showed that Ig mu-/- NOD mice fail to develop diabetes, and showed only minor insulitis. In addition, our preliminary studies have showed that NOD/scid mice that received naive T and B cells isolated from young NOD mice (TB NOD/scid mice), but not NOD/scid mice that received naive T cell alone (T NOD/scid mice), develop spontaneous T cell autoimmune responses and T1DM. Ig mu-/- NOD mice reconstituted with syngeneic bone marrow cells and mature B cells isolated from young NOD mice (Ig mu-/- BMB NOD mice), but not with bone marrow cells alone cells (Ig mu-/- BM NOD mice), display spontaneous T cell responses to beta cell antigens and become diabetic. We hypothesize that B cells are a necessary component for determinant spreading of T cell autoimmunity to beta cell antigens during the natural process of T1DM and following antigen-based immunotherapy.
In this proposal, we will examine the role of B cells in determinant spreading of Th1 and Th2 immunity during spontaneous development of T1DM and following antigen-based immunotherapy in the TB NOD/scid and T NOD/scid mice and in the Ig mu-/- BMB NOD and Ig mu-/- BM NOD mice. These studies will address fundamental questions concerning the role of B cells in T cell autoimmunity and may provide a basis to develop novel immunotherapies for the intervention of human IDDM.
描述(由申请人提供):我们之前的研究以及其他人的研究发现,NOD 小鼠对 GAD 及其肽决定簇产生自发的脾 Th1 细胞反应,然后在 T1DM 过程中在分子内和分子间传播到其他 β 细胞自身抗原。用单一 β 细胞抗原治疗年轻的 NOD 小鼠会引发 Th2 反应,并且诱导的 Th2 反应会扩散到其他不相关的 β 细胞抗原,这与抑制疾病进展有关。然而,人们对抗原呈递细胞 (APC) 在 NOD 小鼠 T 细胞自身免疫的决定性传播中的作用知之甚少。 B 细胞可能是介导 T 细胞自身免疫决定簇传播的良好候选者,因为 B 细胞可以通过其抗原受体捕获抗原来浓缩抗原,有效地处理抗原并将其呈递给 T 细胞。最近的研究表明,Ig mu-/- NOD 小鼠不会患上糖尿病,仅表现出轻微的胰岛炎。此外,我们的初步研究表明,接受从年轻NOD小鼠(TB NOD/scid小鼠)中分离出的初始T细胞和B细胞的NOD/scid小鼠,而不是仅接受初始T细胞(T NOD/scid小鼠)的NOD/scid小鼠,会产生自发的T细胞自身免疫反应和T1DM。 Ig mu-/- NOD 小鼠用同基因骨髓细胞和从年轻 NOD 小鼠分离的成熟 B 细胞(Ig mu-/- BMB NOD 小鼠)重建,但不使用单独的骨髓细胞(Ig mu-/- BM NOD 小鼠),显示出对 β 细胞抗原的自发 T 细胞反应并成为糖尿病。我们假设,在 T1DM 的自然过程中以及基于抗原的免疫治疗后,B 细胞是 T 细胞自身免疫对 β 细胞抗原的决定性传播的必要组成部分。
在本提案中,我们将在 TB NOD/scid 和 T NOD/scid 小鼠以及 Ig mu-/- BMB NOD 和 Ig mu-/- BM NOD 小鼠中检查 T1DM 自发发展期间以及基于抗原的免疫治疗后,B 细胞在 Th1 和 Th2 免疫的决定性传播中的作用。这些研究将解决有关 B 细胞在 T 细胞自身免疫中的作用的基本问题,并可能为开发用于干预人类 IDDM 的新型免疫疗法提供基础。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid.
- DOI:10.1021/jm800167u
- 发表时间:2008-08-14
- 期刊:
- 影响因子:7.3
- 作者:Chen L;Zhang Y;Kong X;Lan E;Huang Z;Peng S;Kaufman DL;Tian J
- 通讯作者:Tian J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIDE TIAN其他文献
JIDE TIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIDE TIAN', 18)}}的其他基金
PDL1-based rAAV-mediated gene therapy for mouse T1D
基于 PDL1 的 rAAV 介导的小鼠 T1D 基因治疗
- 批准号:
7094761 - 财政年份:2006
- 资助金额:
$ 7.63万 - 项目类别:
A Derivative of Oleanolic Acid: Anti-Hepatocellular Carcinoma (HCC) Activity
齐墩果酸衍生物:抗肝细胞癌 (HCC) 活性
- 批准号:
7268008 - 财政年份:2006
- 资助金额:
$ 7.63万 - 项目类别:
A Derivative of Oleanolic Acid: Anti-HCC Activity
齐墩果酸衍生物:抗 HCC 活性
- 批准号:
7147823 - 财政年份:2006
- 资助金额:
$ 7.63万 - 项目类别:
PDL1-based rAAV-mediated gene therapy for mouse T1D
基于 PDL1 的 rAAV 介导的小鼠 T1D 基因治疗
- 批准号:
7230208 - 财政年份:2006
- 资助金额:
$ 7.63万 - 项目类别:
NOD B Cells in Determinant Spreading of T Cell Immunity
NODB 细胞在 T 细胞免疫的决定性传播中
- 批准号:
6597856 - 财政年份:2003
- 资助金额:
$ 7.63万 - 项目类别:
Genetic Modification of Mouse Islets for Transplantation
用于移植的小鼠胰岛基因改造
- 批准号:
6553141 - 财政年份:2002
- 资助金额:
$ 7.63万 - 项目类别:
Genetic Modification of Mouse Islets for Transplantation
用于移植的小鼠胰岛基因改造
- 批准号:
6650359 - 财政年份:2002
- 资助金额:
$ 7.63万 - 项目类别:
Genetic Modification of DCs as Immunotherapy for IDDM
DC 基因修饰作为 IDDM 的免疫疗法
- 批准号:
6400201 - 财政年份:2001
- 资助金额:
$ 7.63万 - 项目类别:
Genetic Modification of DCs as Immunotherapy for IDDM
DC 基因修饰作为 IDDM 的免疫疗法
- 批准号:
6523686 - 财政年份:2001
- 资助金额:
$ 7.63万 - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
$ 7.63万 - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
$ 7.63万 - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
$ 7.63万 - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
$ 7.63万 - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
$ 7.63万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
$ 7.63万 - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
$ 7.63万 - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
$ 7.63万 - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 7.63万 - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
$ 7.63万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




